Literature DB >> 18576176

The role of partnership dynamics in determining the acceptability of condoms and microbicides.

C M Montgomery1, S Lees, J Stadler, N S Morar, A Ssali, B Mwanza, M Mntambo, J Phillip, C Watts, R Pool.   

Abstract

Microbicides are a class of substances under development that could reduce the sexual transmission of HIV and other sexually transmitted diseases when applied locally to genital mucosal surfaces. Microbicide acceptability research has largely focused on product characteristics, rather than processes of negotiation within relationships about use. Gender relations, decision-making power and communication within sexual relationships are recognised as important determinants of condom and contraceptive use, and are likely to determine microbicide use also. As part of social science research linked to the Microbicides Development Programme (MDP) we combine relationship-based theories with anthropological work conducted with women and men using a placebo gel. We explore communication and decision-making in gel and condom use, including constructions of risk and trust. During the MDP301 Phase III pilot study, in-depth interviews were conducted at sites in South Africa, Tanzania, Uganda and Zambia. Following four weeks of placebo gel use, women and their partners were asked about gel use and acceptability, partner involvement, sexual practices and condom use. Data from 45 couples at five sites were analysed using a grounded theory approach in NVivo. Participation in the study did not require women to inform their partners, yet our data shows women seeking permission from their partners, negotiating disclosure, exchanging information and persuading or motivating for gel use. Although gel was supposedly 'woman-controlled', men exercised considerable influence in determining whether and how it was used. Despite this, negotiations around use were largely successful, since the gel increased sexual pleasure and provided opportunities for intimate communication and the building of trust. Decisions about condom and microbicide use are made in a dyadic context and involve a complex negotiation of risk and trust. Whilst preferences relating to product characteristics are largely individual, use itself is dependent on partnership dynamics and the broader social context in which sexual risk management occurs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18576176     DOI: 10.1080/09540120701693974

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  62 in total

1.  Sexual communication among married couples in the context of a microbicide clinical trial and acceptability study in Pune, India.

Authors:  Heather M Marlow; Elizabeth E Tolley; Rewa Kohli; Sanjay Mehendale
Journal:  Cult Health Sex       Date:  2010-11

2.  Reducing sexual risk behavior among high-risk couples in Northern India.

Authors:  Deborah Jones; Rashmi Bagga; Ritu Nehra; Sunil Sethi; Kamini Walia; Mahendra Kumar; Olga Villar-Loubet; Maria Lopez; Stephen M Weiss
Journal:  Int J Behav Med       Date:  2013-09

3.  The Role of Condom Use Self-Efficacy on Intended and Actual Condom Use Among University Students in Ghana.

Authors:  Kwaku Oppong Asante; Joseph Osafo; Paul N Doku
Journal:  J Community Health       Date:  2016-02

4.  Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya.

Authors:  Jennifer J Carroll; Kenneth Ngure; Renee Heffron; Kathryn Curran; Nelly R Mugo; Jared M Baeten
Journal:  AIDS Care       Date:  2016-01-11

5.  [Gender and Sexual Practices: Their Role in the Prevention of HIV/AIDS.]

Authors:  María Del Carmen Cabrera-Aponte; David Pérez-Jiménez; Irma Serrano-García; Nelson Varas-Díaz
Journal:  Cienc Conducta       Date:  2009

Review 6.  A Synthesis of 20 Years of Research on Sexual Risk Taking Among Asian/Pacific Islander Men Who Have Sex With Men in Western Countries.

Authors:  Chen Shi Shiu; Dexter R Voisin; Wet-Ti Chen; Yi-An Lo; Melissa Hardestry; Huong Nguyen
Journal:  Am J Mens Health       Date:  2015-01-06

7.  Acceptability and use of a dapivirine vaginal ring in a phase III trial.

Authors:  Elizabeth T Montgomery; Ariane van der Straten; Miria Chitukuta; Krishnaveni Reddy; Kubashni Woeber; Millicent Atujuna; Linda-Gail Bekker; Juliane Etima; Teopista Nakyanzi; Ashley J Mayo; Ariana Katz; Nicole Laborde; Cynthia I Grossman; Lydia Soto-Torres; Thesla Palanee-Phillips; Jared M Baeten
Journal:  AIDS       Date:  2017-05-15       Impact factor: 4.177

8.  Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.

Authors:  E Pleasants; T Tauya; K Reddy; B G Mirembe; K Woeber; T Palanee-Phillips; C Zimba; M Atujuna; E T Montgomery
Journal:  AIDS Behav       Date:  2020-03

9.  Motivations for PrEP-Related Interpersonal Communication Among Women Who Inject Drugs: A Qualitative Egocentric Network Study.

Authors:  Marisa Felsher; Emmanuel Koku; Stephen Lankenau; Kathleen Brady; Scarlett Bellamy; Alexis M Roth
Journal:  Qual Health Res       Date:  2020-09-01

10.  PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

Authors:  Sheena McCormack; Gita Ramjee; Anatoli Kamali; Helen Rees; Angela M Crook; Mitzy Gafos; Ute Jentsch; Robert Pool; Maureen Chisembele; Saidi Kapiga; Richard Mutemwa; Andrew Vallely; Thesla Palanee; Yuki Sookrajh; Charles J Lacey; Janet Darbyshire; Heiner Grosskurth; Albert Profy; Andrew Nunn; Richard Hayes; Jonathan Weber
Journal:  Lancet       Date:  2010-09-17       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.